The Higher Education Commission of Pakistan is set to showcase cutting-edge lab-to-market innovations developed through its Rs 2.9 billion Technology Development Fund at a major national event ...

Two young creators built a project with nothing but sketches, curiosity and purpose. Their journey revealed core lessons every founder can apply today. I watched two young entrepreneurs turn their ...

About The Study: In this cohort study of patients with type 2 diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) use was associated with body mass index (BMI) -dependent cardiovascular ...

When used as first-line therapy in patients with type 2 diabetes (T2D), GLP-1 receptor agonists (RAs) seemed to be more effective than metformin at reducing the risk for dementia, particularly ...

A U.S. Air Force B-2 prepares to take off for strikes on Iranian facilities on June 21, 2025. Credit: U.S. Air Force LONDON—The unprecedented strikes by seven B-2s that flew deep into Iran last month ...

GLP-1 RAs do not increase risk for acute pancreatitis among individuals with type 2 diabetes. Treatment with GLP-1 receptor agonists (GLP-1 RAs) among patients with type 2 diabetes (T2D) does not ...

Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.

Abstract: The world is facing unavoidable disaster challenges, especially floods in Thailand, these inundations have been becoming increasingly difficult to manage each year. Therefore, a preliminary ...

The U.S. is often considered a lucrative location for international entrepreneurs, as it is known for providing a stable economy and an environment conducive to businesses. The E-2 investor visa is ...

GLP-1 RAs and SGLT2 inhibitors significantly reduce cardiovascular events and heart failure risk in older adults with type 2 diabetes compared to DPP-4 inhibitors. The study utilized health registry ...